About
Matthias Steger is a Swiss biotech entrepreneur focused on longevity, regenerative medicine, and age-related disease therapeutics. He co-founded Rejuveron in 2019, which later rebranded to Centenara Labs in 2024, and he is also co-founder and publicly listed CEO of Endogena Therapeutics. Earlier in his career he held senior partnering roles at Roche and has been active in regenerative-medicine industry organizations.
Areas of interest
longevityaging biologybiotechregenerative medicineclinical-stage drug developmentophthalmologysenescence therapeuticssarcopenianeurodegenerationventure buildinglife sciences